Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion (original) (raw)

• Watanabe R et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen J Immunol 1992 148: 1274–1279
  Google Scholar
• Leithäuser F et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells Lab Invest 1993 69: 415–429
  Google Scholar
• French LE et al. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and co-expression in adult tissues characterized by apoptotic cell turnover J Cell Biol 1996 133: 335–343
  Article CAS Google Scholar
• Schelling JR et al. Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure Lab Invest 1998 78: 813–824
  CAS Google Scholar
• Ashany D et al. Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway Proc Natl Acad Sci USA 1995 92: 11225–11229
  Article CAS Google Scholar
• Rensing-Ehl A et al. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo Eur J Immunol 1995 25: 2253–2258
  Article CAS Google Scholar
• White CA, McCombe PA, Pender MP . Microglia are more susceptible than macrophages to apoptosis in the central nervous system in experimental autoimmune encephalomyelitis through a mechanism not involving Fas (CD95) Int Immunol 1998 10: 935–941
  Article CAS Google Scholar
• Garrone P et al. Fas ligation induces apoptosis of CD40-activated human B-lymphocytes J Exp Med 1995 182: 1265–1273
  Article CAS Google Scholar
• Griffith TS et al. Fas ligand-induced apoptosis as a mechanism of immune privilege Science 1995 270: 1189–1192
  Article CAS Google Scholar
• Bennett MW et al. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer Gut 1999 44: 156–162
  Article CAS Google Scholar
• Gutierrez LS et al. The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas Breast Cancer Res Treat 1999 54: 245–253
  Article CAS Google Scholar
• Hahne M et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape Science 1996 274: 1363–1366
  Article CAS Google Scholar
• O'Connell J et al. The Fas counterattack: Fas-mediated T-cell killing by colon cancer cells expressing Fas ligand J Exp Med 1996 184: 1075–1082
  Article CAS Google Scholar
• Ungefroren H et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis Cancer Res 1998 58: 1741–1749
  CAS Google Scholar
• Xerri L et al. Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis Leukemia 1997 11: 1868–1877
  Article CAS Google Scholar
• Peduto Eberl L et al. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas Int J Cancer 1999 81: 772–778
  Article CAS Google Scholar
• Brown SB, Savill J . Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes J Immunol 1999 162: 480–485
  CAS Google Scholar
• Yoong KF et al. Fas/Fas ligand interaction in human colorectal hepatic metastases: a mechanism of hepatocyte destruction to facilitate local tumor invasion Am J Pathol 1999 154: 693–703
  Article CAS Google Scholar
• Ju DW, Cao X, Acres B . Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model Cancer Gene Therapy 1997 4: 139–144
  CAS PubMed Google Scholar
• Morton D et al. Immunological factors which influence response to immunotherapy in malignant melanoma Surgery 1970 68: 158–163
  CAS PubMed Google Scholar
• Ramsdell F et al. Differential ability of Th1 and Th2 T-cells to express Fas ligand and to undergo activation-induced cell death Int Immunol 1994 6: 1545–1553
  Article CAS Google Scholar
• Alderson MR et al. Fas ligand mediates activation-induced cell death in human T lymphocytes J Exp Med 1995 181: 71–77
  Article CAS Google Scholar
• Mandik L et al. Fas receptor expression on B-lineage cells Eur J Immunol 1995 25: 3148–3154
  Article CAS Google Scholar
• Kume T et al. Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach Int J Cancer 1999 84: 339–343
  Article CAS Google Scholar
• Rafi AQ et al. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome J Immunol 1998 161: 3077–3086
  CAS PubMed Google Scholar
• Allgaier B et al. Spontaneous and Fas-mediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils J Leuk Biol 1998 64: 331–336
  Article CAS Google Scholar
• Jane SM, Cunningham JM, Vanin EF . Vector development: a major obstacle in human gene therapy Ann Med 1998 30: 413–415
  Article CAS Google Scholar
• Lau HT et al. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice Science 1996 273: 109–112
  Article CAS Google Scholar
• Kang SM et al. Immune response and myoblasts that express Fas ligand Science 1997 278: 1322–1324
  Article CAS Google Scholar
• Manfred V, Jürgen M, Reet K . Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas Anticancer Res 1999 19: 1669–1675
  Google Scholar